Epidemiological Characteristics of HIV-Infected Individuals by the Registration for Special Exempted Calculation: A Nationwide Cohort Study
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background The Korean government is implementing policy to reduce medical costs and improve treatment related for human immunodeficiency virus (HIV) patients. The level of cost reduction and the benefits provided vary depending on how individuals with HIV utilize the system. This study aims to determine exact HIV prevalence by analyzing healthcare utilization patterns and examining differences in healthcare usage based on how individuals pay for their medical expenses. Materials and Methods We analyzed National Health Insurance Service (NHIS) claims data from 2002 to 2021. From a total of 106,675 individuals with at least one HIV-related claim, 22,779 participants were selected for this study. Results Data from Korea Disease Control and Prevention Agency annual reports indicated that 93% of HIV patients were male, while NHIS data showed 84%. In the analysis of those exempted from registration, it was found that the registration rate for female patients is notably low, with adults between the ages of 20 and 40 making up 80% of the total. The registration rate in Gangwon State was lower than Seoul. The treatment experience rate was much higher in the registered group (93.0%) than the unregistered group (4.9%). Also, there was a big difference in treatment continuity rates: 76.2% for registered individuals and 2.8% for non-registered individuals. Conclusion The exempt calculation system for health insurance improves HIV care. However, those diagnosed anonymously or with reduced medical costs may be less likely to continue HIV treatment, so a new policy is needed to ensure anonymity and treatment continuity.
Abstract
Background The Korean government is implementing policy to reduce medical costs and improve treatment related for human immunodeficiency virus (HIV) patients. The level of cost reduction and the benefits provided vary depending on how individuals with HIV utilize the system. This study aims to determine exact HIV prevalence by analyzing healthcare utilization patterns and examining differences in healthcare usage based on how individuals pay for their medical expenses. Materials and Methods We analyzed National Health Insurance Service (NHIS) claims data from 2002 to 2021. From a total of 106,675 individuals with at least one HIV-related claim, 22,779 participants were selected for this study. Results Data from Korea Disease Control and Prevention Agency annual reports indicated that 93% of HIV patients were male, while NHIS data showed 84%. In the analysis of those exempted from registration, it was found that the registration rate for female patients is notably low, with adults between the ages of 20 and 40 making up 80% of the total. The registration rate in Gangwon State was lower than Seoul. The treatment experience rate was much higher in the registered group (93.0%) than the unregistered group (4.9%). Also, there was a big difference in treatment continuity rates: 76.2% for registered individuals and 2.8% for non-registered individuals. Conclusion The exempt calculation system for health insurance improves HIV care. However, those diagnosed anonymously or with reduced medical costs may be less likely to continue HIV treatment, so a new policy is needed to ensure anonymity and treatment continuity.
참고문헌 (18)
- "UNAIDS DATA 2023"[URL]
- Kim Y, "Impact of COVID-19 on human immunodeficiency virus tests, new diagnoses, and healthcare visits in the Republic of Korea : a retrospective study from 2016 to 2021", Osong Public Health Res Perspect, 15, pp.340~352 (2024)
- "KIHASA 2021"[URL]
- "HIV/AIDS management guideline in Korea"[URL]
- The Korean Society for AIDS, "Clinical guidelines for the diagnosis and treatment of HIV", AIDS in HIV-infected Koreans, 2011, pp.43, 89~128
- Korean Society for AIDS, "Summary of 2021 clinical guidelines for the diagnosis and treatment of HIV", AIDS in HIV-infected Koreans, 2021, pp.53, 592~616
- Sohn A, "HIV", AIDS knowledge, stigmatizing attitudes, and related behaviors and factors that affect stigmatizing attitudes against HIV, Osong Public Health Res Perspect, pp.2012, 3[DOI]
- Choi JY, "HIV Stigmatization harms individuals and public health", Infect Chemother, 46, pp.139~140 (2014)
- Kim IO, "The effect of social stigma on suicidal ideation of male HIV infected people : focusing on the mediating effect of hope and depression", Korean J Adult Nurs, 26, pp.563~572 (2014)
- Cho HW, "Discrimination and stigma", Osong Public Health Res Perspect, 6, pp.141~142 (2015)
- Lee HJ, "Factors associated with HIV", AIDS-related stigma and discrimination by medical professionals in Korea : a survey of infectious disease specialists in Korea, 2019, pp.22, 675~681
- Shim MS, "Factors influencing young Korean men's knowledge and stigmatizing attitudes about HIV infection", Int J Environ Res Public Health, 17, pp.8076~ (2020)
- Choi JP, "HIV-related stigma reduction in the era of undetectable equals untransmittable : the South Korean perspective", Infect Chemother, 53, pp.661~675 (2021)
- Person AK, "Principles for ending human immunodeficiency virus as an epidemic in the United States : a policy paper of the Infectious Diseases Society of America and the HIV medical association", Clin Infect Dis, 76, pp.1~9 (2023)
- Gallant JE, "Essential components of effective HIV care : a policy paper of the HIV Medicine Association of the Infectious Diseases Society of America and the Ryan White Medical Providers Coalition", Clin Infect Dis, 53, pp.1043~1050 (2011)
- Mugavero MJ, "Racial disparities in HIV virologic failure : do missed visits matter?", J Acquir Immune Defic Syndr, 50, pp.100~108 (2009)
- Losina E, "Racial and sex disparities in life expectancy losses among HIV-infected persons in the united states : impact of risk behavior, late initiation, and early discontinuation of antiretroviral therapy", Clin Infect Dis, 49, pp.1570~1578 (2009)
- Verani AR, "HIV policy advancements in PEPFAR partner countries : a review of data from 2010-2016", Glob Public Health, 16, pp.390~400 (2021)